Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
株式のランク #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
株価
$4.06
最終同期: 2024-02-23
時価総額
$145.61M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Theseus Pharmaceuticals, Inc. (THRX)

カテゴリー

Theseus Pharmaceuticals, Inc.(THRX)の株価履歴
終値の最高値: $4.07 (2024-02-01)

終値の最安値: $16.20 (2021-10-01)
Theseus Pharmaceuticals, Inc. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2024 5.46%
2023 -30.80%
2022 -54.19%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH